Disulfiram and glioblastoma

It is a prescription medicine used for alcohol dependence. Anyone considering it in connection with a brain tumour should speak with the neuro-oncology team before taking it, because potential benefit is uncertain and its adverse effects and interactions can complicate care.

Glioblastoma treatment is planned from the tumour's location, the person's health and function, surgical findings, and laboratory features of the tumour. Established care commonly uses brain tumour surgery when feasible, radiotherapy, and chemotherapy in a coordinated plan. Disulfiram is not a substitute for these treatments. Access through a properly governed clinical trial may be discussed if an appropriate option is available.

Repurposing a medicine does not remove its usual risks. Disulfiram changes how the body processes alcohol and can cause a severe reaction when alcohol is consumed. It may also affect the liver, nerves, mood, or thinking and can interact with other medicines. These issues are especially relevant when neurological symptoms and treatment side effects already need close interpretation.

Do not start disulfiram obtained online, borrowed from another person, or left over from previous care. Give the oncology pharmacist a complete list of medicines, supplements, and non-prescription products. Mention liver problems, seizures, severe mental health symptoms, nerve damage, alcohol use, and any previous reaction to the medicine.

If a clinical trial is being considered, ask what treatment is given, how safety is monitored, which visits or tests are required, and whether standard therapy continues. Discuss supportive care at the same appointment; seizure control, steroid management, rehabilitation, and symptom relief can materially affect daily function even when the anticancer plan is unchanged.

For a person with glioblastoma, seek emergency help for a first seizure, a seizure that does not stop as instructed in the emergency plan, new one-sided weakness, sudden difficulty speaking, loss of consciousness, or a rapidly worsening severe headache with repeated vomiting. If disulfiram has been taken, urgent assessment is also needed for chest pain, trouble breathing, fainting, severe confusion, yellowing of the skin or eyes, or thoughts of self-harm.

Ask whether disulfiram is being offered only within a clinical trial, what uncertainties remain, and what known interactions apply to your current medicines. Request a clear explanation of the recommended standard treatment, alternatives, likely side effects, and how the team will assess whether therapy is helping.